Abstract
Immunosuppressive therapy is not only an etiologic factor ofde novo malignant disease but it also accelerates progression of the already developed malignant disease in immunosuppressed recipients. Two cases ofde novo breast cancer arising in kidney transplant recipients are reported herein. A 25 year-old woman, transplanted one haploidentical kidney transplant 4 years and 9 months ago, developed a left breast tumor. Within one month the tumor had rapidly enlarged from 3.5 cm to 8 cm in diameter by the time she underwent a radical mastectomy. Nine axillary lymph nodes were positive for metastasis. Although her graft function had been poor due to chronic rejection, she was treated with standard immunosuppressive therapy, but not adjuvant therapy. Since local recurrent disease appeared two months postoperatively, the immunosuppressive therapy was ceased and60Co therapy started. Recurrent disease progressed rapidly, however, and she died 7 months after her operation. A 27 year-old woman, having allograft from an identical sibling, noted a right breast tumor, 8 years and 7 months later. Again the tumor had grown rapidly from 1.8 cm to 3 cm in diameter within one month. She underwent a standard radical mastectomy. One axillary lymph nodes was positive for metastasis. She has been treated with standard immunosuppressive therapy and adjuvant endocrinochemotherapy. Presently, she is alive with a well functioning graft and no disease.
Similar content being viewed by others
References
Penn I. The incidence of malignancies in transplant recipients. Transplant Proc 1975; 7: 323–326.
Penn I. Cancer is a complication of severe immuno-suppression. Surg Gynecol Obstet 1986; 162: 603–610.
Doak PB, Montgomerie JL, North JD, Smith F. Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Brit Med J 1968; 4: 746–748.
Sheil AGR. Cancer in dialysis and transplant recipients. In: Morris PJ, ed. Kidney transplantation principles and practice. New York: Grune & Stratton. 1984; 491–507.
Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc 1977; 9: 1121–1127.
Sheil AGR. Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc 1977; 9: 1133–1136.
Sheil AGR, Mahony JF, Horvath JS, Johnson JR, Tiller DJ, Stewart JH, May J. Cancer following successful cadaveric donor renal transplantation. Transplant Proc 1981; 13: 733–735.
Ochiai T, Asano T, Isano K. Development of malignancies in Japanese renal transplant recipients. Transplant Proc 1987; 19: 2967–2970.
Bast R. Principles of cancer biology: Tumor immunology. In: DeVita VT, Hellman S, Rosenberg G, eds. Cancer: Principles and practice of oncology. Philadelphia: JB Lippincott Company 1985; 125–150.
Sheil AGR, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, May J, Stewart JH. Cancer and survival after cadaveric donor renal transplantation. Transplant Proc 1979; 11: 1052–1054.
Penn I. Cancer following cyclosporine therapy. Transplantation 1987; 43: 32–35.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yasumura, T., Ohmori, Y., Aikawa, I. et al. Breast cancer arisingde novo in recipients of kidney allograft. The Japanese Journal of Surgery 19, 370–375 (1989). https://doi.org/10.1007/BF02471416
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471416